Lumiera Health Inc.
NHPHF
OTC PK
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -34.75% | -26.13% | -6.70% | 13.30% | 25.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -34.75% | -26.13% | -6.70% | 13.30% | 25.77% |
| Cost of Revenue | 8.19% | 17.99% | 41.88% | 71.57% | 14.55% |
| Gross Profit | -82.26% | -73.41% | -56.77% | -46.62% | 41.07% |
| SG&A Expenses | -66.92% | -58.28% | -43.99% | -25.05% | -7.55% |
| Depreciation & Amortization | -65.76% | -45.66% | -24.71% | -2.82% | 30.22% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -54.24% | -46.50% | -31.91% | -12.10% | -3.13% |
| Operating Income | 63.42% | 54.63% | 40.76% | 20.42% | 12.58% |
| Income Before Tax | 8.41% | -6.82% | -382.07% | -205.67% | -20.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.41% | -6.82% | -382.07% | -205.67% | -20.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.41% | -6.82% | -382.07% | -205.67% | -20.32% |
| EBIT | 63.42% | 54.63% | 40.76% | 20.42% | 12.58% |
| EBITDA | 63.25% | 55.18% | 41.66% | 21.38% | 14.59% |
| EPS Basic | 50.33% | 42.31% | -65.08% | -8.77% | -17.97% |
| Normalized Basic EPS | 87.78% | 83.06% | 68.80% | 66.67% | -91.49% |
| EPS Diluted | 50.33% | 42.31% | -65.08% | -8.77% | -17.97% |
| Normalized Diluted EPS | 87.78% | 83.06% | 68.80% | 66.67% | -91.49% |
| Average Basic Shares Outstanding | 25.05% | 29.41% | 49.42% | 77.12% | 27.48% |
| Average Diluted Shares Outstanding | 25.05% | 29.41% | 49.42% | 77.12% | 27.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
